Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$576.64 - $649.04 $4,613 - $5,192
-8 Closed
0 $0
Q4 2020

Feb 08, 2021

SELL
$510.68 - $643.45 $1,021 - $1,286
-2 Reduced 20.0%
8 $5,000
Q3 2020

Nov 06, 2020

SELL
$454.43 - $535.6 $3,635 - $4,284
-8 Reduced 44.44%
10 $5,000
Q2 2020

Jul 15, 2020

BUY
$334.87 - $493.06 $1,004 - $1,479
3 Added 20.0%
18 $8,000
Q2 2019

Aug 12, 2019

SELL
$286.93 - $312.59 $573 - $625
-2 Reduced 11.76%
15 $5,000
Q1 2019

Apr 29, 2019

BUY
$224.3 - $317.41 $448 - $634
2 Added 13.33%
17 $5,000
Q4 2018

Feb 04, 2019

SELL
$220.1 - $309.0 $1,100 - $1,545
-5 Reduced 25.0%
15 $3,000
Q2 2018

Jul 31, 2018

BUY
$244.1 - $303.88 $732 - $911
3 Added 17.65%
20 $6,000
Q1 2018

May 14, 2018

BUY
$233.97 - $274.11 $3,977 - $4,659
17 New
17 $4,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.48B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Howe & Rusling Inc Portfolio

Follow Howe & Rusling Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.